Today: 9 June 2026
IREN stock jumps in midday trade as rate-cut bets keep high-beta names in play
9 January 2026
1 min read

IREN stock jumps in midday trade as rate-cut bets keep high-beta names in play

New York, Jan 9, 2026, 12:45 EST — Regular session

  • IREN shares up about 7% at $48.90, outpacing most listed crypto miners
  • Bitcoin steadies near $91,000 as broader U.S. stocks edge higher
  • Focus turns to funding and buildout milestones ahead of February results

IREN Limited shares rose about 7% to $48.90 on Friday, extending a choppy week for the Nasdaq-listed stock as traders leaned back into higher-risk names. Bitcoin was little changed near $91,067, while peers were mixed, with Riot Platforms up about 3% and Marathon Digital down about 0.4%.

The move comes with U.S. stocks grinding higher after a softer December jobs report left expectations for Federal Reserve rate cuts broadly intact. “This is a report that’s somewhat within the range of expectations of investors, so they’re not reacting,” Mark Hackett, chief market strategist at Nationwide, said. Reuters

For IREN investors, the near-term question is whether the company can keep execution tight as it tries to turn itself from a bitcoin miner into a power-and-data-center platform for AI workloads. The company has a five-year, $9.7 billion contract with Microsoft tied to deployments of Nvidia graphics processing units (GPUs — chips widely used to run AI models) through 2026, with Dell supplying about $5.8 billion of equipment, Reuters has reported.

That backdrop makes the stock sensitive to shifts in rates and risk appetite, but also to any sign the buildout is slipping. The Microsoft contract can be terminated if delivery timelines are missed, Reuters reported, putting extra weight on commissioning schedules and equipment delivery into 2026.

Still, the upside case depends on heavy spending and steady access to power, hardware and financing. Any delays in bringing capacity online, or a renewed slump in crypto-linked sentiment, can hit a stock that has tended to trade like a leveraged bet on both AI infrastructure and bitcoin.

The next hard check-in is earnings. Zacks’ earnings calendar pegs IREN’s next report around Feb. 11, based on prior reporting patterns, though dates can shift if the company updates its schedule.

Stock Market Today

  • Washington's Railroad Rule Changes Threaten U.S. Supply Chain
    June 9, 2026, 9:15 AM EDT. Congress and the White House are quietly imposing new regulations on U.S. railroads, a critical component of the national economy. These changes, seen as micromanagement, could disrupt freight movement and supply chains. The timing raises concerns amid ongoing economic pressures and recovery efforts post-pandemic. Rail networks handle bulk goods and industrial materials vital to commerce. Industry experts warn that increased federal oversight may hinder operational efficiency and investment. Delays or inefficiencies in rail transport could ripple through markets, affecting costs and delivery times across sectors. Stakeholders urge a balanced approach to regulation to ensure infrastructure resilience without stifling rail companies' flexibility and growth.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves
Previous Story

Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop